Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study refines breast cancer risks

13.02.2002


Increasing age is the strongest risk factor for breast cancer
© SPL


Large scale study spells out links with pregnancy and miscarriage.

Childless women are at a higher risk of developing breast cancer, confirms one of the largest studies on reproductive factors and the disease, but those who suffer miscarriages are not. Researchers are pinning down key risk factors in the hope of working out exactly how they increase susceptibility.

How pregnancy and abortion alter women’s chance of developing breast cancer has been the subject of conflicting reports. A new French study has tracked 90,000 women, aged 40-65, since 1990 and goes some way to clarifying these risks.



Unlike previous work, the report separately calculates how each factor alters risk in both pre- and post-menopausal women. Most significantly, the team found no link between miscarriage and risk of the cancer in pre- or post-menopausal women. This contrasts with previous surveys suggesting a link with induced abortion.

Specialists no longer accept the proposed link to abortion, says breast cancer researcher Mads Medley of the Statens Serum Institut in Denmark. Older studies asked women to recall their abortion history at the time of their diagnosis, which influenced how likely they were to recall such incidents: "You introduce a bias," he explains.

Clavel-Chapelon’s study was prospective - detailed questionnaires were sent out before the onset of cancer and without knowing who would develop the disease. This means that women’s answers were more likely to be unbiased. Eliminating spontaneous abortion as a risk factor "is nice to know," says Medley.

The new study offers "far stronger data in terms of blowing that theory away", agrees Gordon McVie, joint director-general of Cancer Research UK. The study’s three other main findings support previous evidence: that overall breast cancer risk increases the later a woman has her first child, the fewer children she bears and the earlier she starts her periods1.

A woman whose periods began at age 15 is at two-thirds the risk of one who started at 11 or earlier, find Francoise Clavel-Chapelon of the Gustave-Roussy Institute in Villejuif and her team.

But all the variations in risk are small, points out cancer researcher Robin Weiss of University College London and editor of the British Journal of Cancer, which is publishing the work. "They’re very powerful data, but they’re not huge differences," he says.

Increasing age is the strongest risk factor for breast cancer: the older a woman, the more likely she is to develop the disease. Overall, 1 in 8 women in the United States will develop the cancer in their lives; 1 in 9 in Britain.

Immediate impact?

The study is likely to have little immediate impact: women cannot change their reproductive cycle and are unlikely to alter decisions about whether to have children. "It’s difficult to turn it into prevention," admits Clavel-Chapelon.

Instead, scientists hope to work out exactly what happens in the breast during puberty, pregnancy and menopause. When breast tissue prepares for milk production, it may switch on certain genes that are protective; so identifying these genes might lead to treatments. "We can go all the way from looking at populations to looking at molecules in cells," says Weiss.

With this in mind, DNA samples from many of the women in the project have already been collected and stored. The study is part of a bigger international effort to identify other lifestyle factors - such as diet and use of hormone replacement therapy - that may affect risk. "Large studies have the power to dissect these out," says McVie.

References

  1. Clavel-Chapelon, F. and the E3N-EPIC Group Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. British Journal of Cancer, DOI 10.1038/sj/bjc/6600124, (2002).


HELEN PEARSON | © Nature News Service
Further information:
http://www.nature.com/nsu/020211/020211-8.html

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>